BioNTech co-founder Özlem Türeci on ‘hip’ ADCs and the power of combo therapies

CHICA­GO — Özlem Türe­ci took a sev­en-year break from at­tend­ing the Amer­i­can So­ci­ety of Clin­i­cal On­col­o­gy’s an­nu­al meet­ing.

She’d been busy with the Covid-19 pan­dem­ic as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.